Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Zohreh Fay
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-20
properties)
Infobox
Patent primary examiner of
US Patent 7105512 Ophthalmic aqueous pharmaceutical preparation
US Patent 7112588 Use of proteasome inhibitors to treat dry eye disorders
US Patent 7115667 Ophthalmic fluid
US Patent 7122518 Method for preventing or reducing collateral phototoxic damage to neighboring tissues during photodynamic therapy of a target tissue
US Patent 7129272 Apoptosis inhibitor
US Patent RE39609 8-iso-prostaglandins for glaucoma therapy
US Patent 7220780 Naaladase inhibitors for treating retinal disorders and glaucoma
US Patent 7223737 Method of treating dry eye disorders using glycosides
US Patent 7235556 Methods of treating dry eye disorders
US Patent 7247623 Method of treating dry eye disease with non-drying antihistamines
US Patent 7265117 Topical brimonidine tartrate formulations that lack chlorine dioxide
US Patent 7268137 Ocular therapy
US Patent 7321000 Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome
US Patent 7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
US Patent 7335803 Methods and compositions for modulating alpha adrenergic receptor activity
US Patent 7364723 Liquid preparation for contact lenses
US Patent 7977385 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US Patent 7998942 Eye drop preparation comprising xanthan gum and terpenoid
US Patent 8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
US Patent 8008338 Ketorolac tromethamine compositions for treating or preventing ocular pain
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8008338 Ketorolac tromethamine compositions for treating or preventing ocular pain
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998942 Eye drop preparation comprising xanthan gum and terpenoid
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7977385 Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
Edits on 26 Nov, 2021
Golden AI
edited on 26 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7364723 Liquid preparation for contact lenses
Edits on 23 Nov, 2021
Golden AI
edited on 23 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7335803 Methods and compositions for modulating alpha adrenergic receptor activity
Golden AI
edited on 23 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7335682 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
Golden AI
edited on 23 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7321000 Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7268137 Ocular therapy
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7265117 Topical brimonidine tartrate formulations that lack chlorine dioxide
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7247623 Method of treating dry eye disease with non-drying antihistamines
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7235556 Methods of treating dry eye disorders
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7223737 Method of treating dry eye disorders using glycosides
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7220780 Naaladase inhibitors for treating retinal disorders and glaucoma
Golden AI
edited on 22 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent RE39609 8-iso-prostaglandins for glaucoma therapy
Edits on 18 Nov, 2021
Golden AI
edited on 18 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7129272 Apoptosis inhibitor
Golden AI
edited on 18 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7122518 Method for preventing or reducing collateral phototoxic damage to neighboring tissues during photodynamic therapy of a target tissue
Golden AI
edited on 17 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7115667 Ophthalmic fluid
Edits on 17 Nov, 2021
Golden AI
edited on 17 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7112588 Use of proteasome inhibitors to treat dry eye disorders
Load more
Find more people like Zohreh Fay
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE